Cargando…
Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078286/ https://www.ncbi.nlm.nih.gov/pubmed/32179496 http://dx.doi.org/10.1016/j.ebiom.2020.102703 |
| _version_ | 1783507588031184896 |
|---|---|
| author | Vega, Francisco M. Colmenero-Repiso, Ana Gómez-Muñoz, María A. Rodríguez-Prieto, Ismael Aguilar-Morante, Diana Ramírez, Gema Márquez, Catalina Cabello, Rosa Pardal, Ricardo |
| author_facet | Vega, Francisco M. Colmenero-Repiso, Ana Gómez-Muñoz, María A. Rodríguez-Prieto, Ismael Aguilar-Morante, Diana Ramírez, Gema Márquez, Catalina Cabello, Rosa Pardal, Ricardo |
| author_sort | Vega, Francisco M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7078286 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70782862020-03-19 Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma” Vega, Francisco M. Colmenero-Repiso, Ana Gómez-Muñoz, María A. Rodríguez-Prieto, Ismael Aguilar-Morante, Diana Ramírez, Gema Márquez, Catalina Cabello, Rosa Pardal, Ricardo EBioMedicine Letter Elsevier 2020-03-13 /pmc/articles/PMC7078286/ /pubmed/32179496 http://dx.doi.org/10.1016/j.ebiom.2020.102703 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter Vega, Francisco M. Colmenero-Repiso, Ana Gómez-Muñoz, María A. Rodríguez-Prieto, Ismael Aguilar-Morante, Diana Ramírez, Gema Márquez, Catalina Cabello, Rosa Pardal, Ricardo Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma” |
| title | Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma” |
| title_full | Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma” |
| title_fullStr | Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma” |
| title_full_unstemmed | Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma” |
| title_short | Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma” |
| title_sort | response to “high cd44 expression is not a prognosis marker in patients with high-risk neuroblastoma” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078286/ https://www.ncbi.nlm.nih.gov/pubmed/32179496 http://dx.doi.org/10.1016/j.ebiom.2020.102703 |
| work_keys_str_mv | AT vegafranciscom responsetohighcd44expressionisnotaprognosismarkerinpatientswithhighriskneuroblastoma AT colmenerorepisoana responsetohighcd44expressionisnotaprognosismarkerinpatientswithhighriskneuroblastoma AT gomezmunozmariaa responsetohighcd44expressionisnotaprognosismarkerinpatientswithhighriskneuroblastoma AT rodriguezprietoismael responsetohighcd44expressionisnotaprognosismarkerinpatientswithhighriskneuroblastoma AT aguilarmorantediana responsetohighcd44expressionisnotaprognosismarkerinpatientswithhighriskneuroblastoma AT ramirezgema responsetohighcd44expressionisnotaprognosismarkerinpatientswithhighriskneuroblastoma AT marquezcatalina responsetohighcd44expressionisnotaprognosismarkerinpatientswithhighriskneuroblastoma AT cabellorosa responsetohighcd44expressionisnotaprognosismarkerinpatientswithhighriskneuroblastoma AT pardalricardo responsetohighcd44expressionisnotaprognosismarkerinpatientswithhighriskneuroblastoma |